Project Details
Description
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immuno-suppression Trial - EXTended Criteria Donors (Benefit - EXT)
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/04 → 12/1/15 |
Funding
- BRISTOL-MYERS SQUIBB PHARM RES
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.